Lv41
480 积分 2024-09-16 加入
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity
1个月前
已完结
The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy
1个月前
已完结
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
1个月前
已完结
Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetes
2个月前
已完结
Constructing germline research cohorts from the discarded reads of clinical tumor sequences
2个月前
已完结
Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
2个月前
已完结
Cancer immunologists scoop medicine Nobel prize
2个月前
已完结
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
2个月前
已完结
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity
2个月前
已完结
Immuno-oncology drug development goes global
2个月前
已完结
皖公网安备34019202002308
